Camilo Jimenez MD

Dr. Jimenez is an Associate Professor of Endocrine Neoplasia and Hormonal Disorders. He has performed extensive clinical research in the field of endocrine cancer with a particular interest in pheochromocytomas and paragangliomas. Dr. Jimenez was one of the first clinicians to describe the use tyrosine kinase inhibitors in patients affected with sporadic and hereditary (Von Hippel-Lindau and Paraganglioma syndrome type 4) malignant pheochromocytomas and sympathetic paragangliomas. His observations led to the development of prospective multi-institutional, international clinical trials. Dr. Jimenez also characterized inherent complications related to excessive hormonal secretion and tumor burden distinctive of this disease.